Screener
LeMaitre Vascular LMAT CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | For the six months ended / June 30, 2026 | For the six months ended / June 30, 2025 |
|---|---|---|
| Net cash provided by operating activities | 31,058 | 29,330 |
| Investing activities | ||
| Purchases of short-term marketable securities | (231,434) | (17,849) |
| Purchases of property and equipment | (5,096) | (2,725) |
| Payments related to acquisitions, net of cash acquired | (158) | (95) |
| Proceeds from short-term marketable securities | 212,489 | — |
| Net cash used in investing activities | (24,199) | (20,669) |
| Financing activities |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's capex?
- LeMaitre Vascular (LMAT) reported capex of $2.31M in Q2 2026.
- How has LeMaitre Vascular's capex changed year-over-year?
- LeMaitre Vascular's capex increased by 72.4% year-over-year, from $1.34M to $2.31M.
- What is the long-term trend for LeMaitre Vascular's capex?
- Over 3 years (2022 to 2025), LeMaitre Vascular's capex has grown at a 28.1% compound annual growth rate (CAGR), from $3.23M to $6.78M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about LeMaitre Vascular's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude